AKEBIA THERAPEUTICS, INC. Increase (Decrease) in Unbilled Receivables
AKEBIA THERAPEUTICS, INC. (AKBA) reported Increase (Decrease) in Unbilled Receivables of -$33.54 million for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-08.
Discontinued › Notes › ASU 2014-09 Transition
us-gaap:IncreaseDecreaseInUnbilledReceivables · last filed 2017-11-08
- AKEBIA THERAPEUTICS, INC. increase (decrease) in unbilled receivables for the quarter ending 2017-09-30 was $281.00K.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in unbilled receivables for the quarter ending 2017-06-30 was $0.00.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in unbilled receivables for the quarter ending 2017-03-31 was -$33.82M.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in unbilled receivables for fiscal 2016 was $33.82M.
| Period end | Increase (Decrease) in Unbilled Receivables 3 month | Increase (Decrease) in Unbilled Receivables 6 month | Increase (Decrease) in Unbilled Receivables 9 month | Increase (Decrease) in Unbilled Receivables 12 month |
|---|---|---|---|---|
| 2017-09-30 | $281.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $281.00K derived: sum of 2 quarters · filed 2017-11-08 | -$33.54M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$33.82M 10-Q · filed 2017-08-08 | ||
| 2017-03-31 | -$33.82M 10-Q · filed 2017-05-09 | |||
| 2016-12-31 | $33.82M 10-K · filed 2017-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |